Pfizer and BioNTech publish results of study showing COVID-19 vaccine elicits antibodies that neutralize pseudovirus bearing the SARS-CoV-2 U.K. strain spike protein
- Details
- Category: Business

Valneva in advanced discussions with European Commission to supply up to 60 million doses of inactivated, adjuvanted COVID-19 vaccine candidate
- Details
- Category: Business

An in vitro study shows Pfizer-BioNTech COVID-19 vaccine elicits antibodies that neutralize SARS-CoV-2 with a mutation associated with rapid transmission
- Details
- Category: Business

European Commission authorizes COVID-19 vaccine Moderna in Europe
- Details
- Category: Business

China grants conditional market approval for Sinopharm CNBG's COVID-19 vaccine
- Details
- Category: Business
The inactivated COVID-19 vaccine developed by Beijing Institute of Biological Products of Sinopharm CNBG has been granted conditional registration by the NMPA of China, Chinese equivalent of FDA, according to a press conference of the State Council Joint Prevention and Control Mechanism on December 31, 2020,
Moderna provides COVID-19 vaccine supply update
- Details
- Category: Business

Novavax announces initiation of PREVENT-19 pivotal Phase 3 efficacy trial of COVID-19 vaccine in the United States and Mexico
- Details
- Category: Business

More Pharma News ...
- Valneva initiates Phase 1/2 clinical study of inactivated, adjuvanted COVID-19 vaccine candidate
- Moderna announces first participants dosed in Phase 2/3 study of COVID-19 vaccine candidate in adolescents
- Moderna announces primary efficacy analysis in Phase 3 COVE study for its COVID-19 vaccine candidate and filing today with U.S. FDA for Emergency Use Authorization
- Moderna's COVID-19 vaccine candidate meets its primary efficacy endpoint in the first interim analysis of the Phase 3 COVE study
- Swissmedic begins rolling review of Moderna's mRNA vaccine against COVID-19 (mRNA-1273)
- The Sputnik V COVID-19 vaccine efficacy amounted to 92% in Phase III clinical trials
- Novavax COVID-19 vaccine granted Fast Track Designation by U.S. FDA